This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Men's Health  • Prostate Disease  • Alert me on articles by topic

Giuseppe Lippi, MD; Martina Montagnana, MD; Gian Cesare Guidi, MD

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with interest the recent article by Kerfoot et al,¹ who concluded that prostate-specific antigen (PSA) screening is commonly performed counter to evidence-based guidelines. We performed a similar analysis, retrieving results of PSA tests performed in the Department of Laboratory Medicine at the University Hospital of Verona, Verona, Italy, which serves an area with a population of 270 000 inhabitants with 750 beds and specialized care units. Similar to the study by Kerfoot et al,¹ data on PSA test use from 2002 to 2007 were obtained from the databases of our laboratory information system for 12 570 male patients, excluding patients who underwent PSA testing for nonscreening reasons, as indicated by prostate cancer–specific medications, diagnoses, and procedures. The percentage of overall inappropriate tests was almost identical to that reported by Kerfoot et al¹ (19.3% vs 19.4%; P = .98 by ² analysis), . . . [Full Text of this Article]

AUTHOR INFORMATION

RELATED ARTICLE

Practitioner-Level Determinants of Inappropriate Prostate-Specific Antigen Screening
B. Price Kerfoot, Erika F. Holmberg, Elizabeth V. Lawler, Edward Krupat, and Paul R. Conlin
Arch Intern Med. 2007;167(13):1367-1372.
ABSTRACT | FULL TEXT